Dual orexin receptor antagonists for treatment of insomnia: A systematic review and meta-analysis on randomized, double-blind, placebo-controlled trials of suvorexant and lemborexant

Study objectivesRecent treatment guidelines for chronic insomnia recommend pharmacological and non-pharmacological therapies. One of the contemporary drug options for insomnia includes dual orexin receptor antagonist (DORA), such as suvorexant and lemborexant. We conducted a systematic review and me...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Habibolah Khazaie, Masoud Sadeghi, Sepideh Khazaie, Max Hirshkowitz, Amir Sharafkhaneh
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Frontiers Media S.A. 2022-12-01
Reeks:	Frontiers in Psychiatry
Onderwerpen:	insomnia orexin receptor antagonist suvorexant lemborexant randomized trial meta-analysis
Online toegang:	https://www.frontiersin.org/articles/10.3389/fpsyt.2022.1070522/full
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!